Morning Overview on MSN
An experimental weight-loss pill just matched the blockbuster injections in a trial — letting patients skip the needle and take a daily tablet instead
For the millions of Americans injecting themselves weekly with Wegovy, Ozempic, Mounjaro, or Zepbound, the promise of a ...
Lilly’s weight loss pill gained approval in April 2026, around three months after Novo Nordisk gained the same accolade for oral Wegovy.
Novo Nordisk (NVO +0.89%) pioneered weight loss medicines with Wegovy, an anti-obesity therapy that quickly became a hit.
Morning Overview on MSN
Eli Lilly’s new obesity pill just stripped 85 pounds off patients in a late-stage trial — the steepest weight loss ever logged without a needle
Participants in Eli Lilly’s TRIUMPH-1 trial lost an average of roughly 85 pounds on the highest dose of retatrutide, an ...
FDA approval of Eli Lilly’s weight-loss pill on April 1 shows the fast-changing landscape for weight loss, obesity ...
GLP-1 shots and pills both help regulate appetite and blood sugar. Learn the differences in effectiveness, cost, and who ...
GLP-1 supplements for weight loss cost less than GLP-1 drugs, but do they work? Doctors and experts explain how much weight you can expect to lose.
By Bhanvi Satija and Chris Prentice LONDON/NEW YORK, May 21 (Reuters) - Lower prices for weight-loss pills from Novo Nordisk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results